Related Experiment Video
Updated: Jul 17, 2025

Preparation of Oligomeric β-amyloid1-42 and Induction of Synaptic Plasticity Impairment on Hippocampal Slices
Published on: July 14, 2010
Cholinergic Reinforcement Signaling Is Impaired by Amyloidosis Prior to Its Synaptic Loss
Simon Allard1, Marshall G Hussain Shuler2
1Kavli Neuroscience Discovery Institute, Department of Neuroscience, Johns Hopkins University School of Medicine, Baltimore, Maryland 21205.
Alzheimer's disease (AD) impairs acetylcholine signaling, crucial for memory, even before synaptic degeneration. This study reveals acetylcholine acts as a reinforcement signal disrupted by amyloidosis in AD mice.
Area of Science:
- Neuroscience
- Alzheimer's Disease Research
- Cholinergic System Function
Background:
- Alzheimer's disease (AD) is linked to amyloidosis and cholinergic system dysfunction, impacting learning and memory.
- The precise nature of acetylcholine signaling in plasticity and its alteration by amyloidosis remains poorly understood.
Purpose of the Study:
- To optically measure acetylcholine release in response to predicted, predicted, and predictive events in the visual cortex of a preclinical AD mouse model.
- To investigate how amyloidosis impacts acetylcholine signaling and its reinforcement qualities before synaptic degeneration.
Main Methods:
- Utilized optical measurement techniques to quantify acetylcholine release profiles in a mouse model of AD with developing amyloidosis.
- Examined acetylcholine signaling in response to unexpected, predicted, and predictive events in the visual cortex.
- Identified and analyzed three distinct stages of amyloidosis.
Main Results:
- Acetylcholine demonstrated reinforcement signaling, reporting behaviorally relevant outcomes and adapting release profiles with experience.
- Cholinergic responses in amyloid-bearing mice were impaired across three stages of amyloidosis, diverging from controls.
- Amyloidosis degraded signaling of unexpected rewards/punishments and attenuated experience-dependent changes in acetylcholine responses to predictive cues and outcomes.
Conclusions:
- Acetylcholine functions as a reinforcement signal that is impaired by amyloidosis prior to cholinergic system degeneration.
- Disrupted cholinergic activity, including transient hyperactivity, may serve as an early functional biomarker for AD.
- Findings enhance understanding of acetylcholine signaling in AD and inform potential therapeutic intervention timing.
Related Concept Videos
Alzheimer's Disease: Treatment
Alzheimer's Disease: Overview
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
Amyloid Fibrils
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining,...
Chemical Synapses
Because chemical synapses depend on the release of neurotransmitter molecules from synaptic vesicles to pass on their signal, there is an approximately one millisecond delay between when the axon potential reaches the presynaptic terminal and when the neurotransmitter leads to opening of postsynaptic ion channels. Additionally, this signaling is...
Indirect-Acting Cholinergic Agonists: Pharmacological Actions
At the neuromuscular junction, these agents work by inhibiting the breakdown of acetylcholine, allowing it to remain bound to the receptor and bind to nearby receptors. This process leads to repetitive firing of the endplate, causing muscle...
Cholinergic Neurons: Neurotransmission

